342 related articles for article (PubMed ID: 26753656)
21. Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women.
Artini PG; Obino MER; Micelli E; Malacarne E; Vacca C; Papini F; Cela V
Gynecol Endocrinol; 2020 Sep; 36(9):755-759. PubMed ID: 32157927
[TBL] [Abstract][Full Text] [Related]
22. Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome.
Fruzzetti F; Capozzi A; Canu A; Lello S
Gynecol Endocrinol; 2019 Jun; 35(6):506-510. PubMed ID: 30612488
[TBL] [Abstract][Full Text] [Related]
23. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
Walls M; Junk S; Ryan JP; Hart R
Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
[TBL] [Abstract][Full Text] [Related]
24. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
25. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
26. Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization.
Vartanyan EV; Tsaturova KA; Devyatova EA; Mikhaylyukova AS; Levin VA; Petuhova NL; Markin AV; Steptsova EM
Gynecol Endocrinol; 2017; 33(sup1):8-11. PubMed ID: 29264980
[TBL] [Abstract][Full Text] [Related]
27. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.
Colazingari S; Treglia M; Najjar R; Bevilacqua A
Arch Gynecol Obstet; 2013 Dec; 288(6):1405-11. PubMed ID: 23708322
[TBL] [Abstract][Full Text] [Related]
28. [Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome].
Ciotta L; Stracquadanio M; Pagano I; Carbonaro A; Palumbo M; Gulino F
Minerva Ginecol; 2010 Dec; 62(6):525-31. PubMed ID: 21079574
[TBL] [Abstract][Full Text] [Related]
29. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
Kdous M; Chaker A; Zhioua A; Zhioua F
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
[TBL] [Abstract][Full Text] [Related]
30. Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome.
Fruzzetti F; Fidecicchi T; Palla G; Gambacciani M
Gynecol Endocrinol; 2020 Feb; 36(2):152-155. PubMed ID: 31317814
[TBL] [Abstract][Full Text] [Related]
31. Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index.
McCormick B; Thomas M; Maxwell R; Williams D; Aubuchon M
Fertil Steril; 2008 Dec; 90(6):2304-9. PubMed ID: 18191852
[TBL] [Abstract][Full Text] [Related]
32. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
Kamenov Z; Kolarov G; Gateva A; Carlomagno G; Genazzani AD
Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724
[TBL] [Abstract][Full Text] [Related]
33. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.
Ciotta L; Stracquadanio M; Pagano I; Carbonaro A; Palumbo M; Gulino F
Eur Rev Med Pharmacol Sci; 2011 May; 15(5):509-14. PubMed ID: 21744744
[TBL] [Abstract][Full Text] [Related]
34. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
Gerli S; Papaleo E; Ferrari A; Di Renzo GC
Eur Rev Med Pharmacol Sci; 2007; 11(5):347-54. PubMed ID: 18074942
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
Mendoza N; Diaz-Ropero MP; Aragon M; Maldonado V; Llaneza P; Lorente J; Mendoza-Tesarik R; Maldonado-Lobon J; Olivares M; Fonolla J
Gynecol Endocrinol; 2019 Aug; 35(8):695-700. PubMed ID: 30880505
[TBL] [Abstract][Full Text] [Related]
36. High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
Mendoza N; Galan MI; Molina C; Mendoza-Tesarik R; Conde C; Mazheika M; Diaz-Ropero MP; Fonolla J; Tesarik J; Olivares M
Gynecol Endocrinol; 2020 May; 36(5):398-401. PubMed ID: 31657275
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
39. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
40. Inositol: effects on oocyte quality in patients undergoing ICSI. An open study.
Brusco GF; Mariani M
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):3095-102. PubMed ID: 24302192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
